RxDoctor Payments Data

Whitney Jablonski

Acute Care · Parma, OHNPI 1841812039

Payments from drug & device makers

$949in general payments, 2019–2025

Across 45 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$146
  • Merz North America, Inc.$128
  • Novartis$123
  • AstraZeneca$95
  • Merck$78
  • Pfizer$74
  • plus $306 from 10 others

What the payments were for

  • Food & beverage$949100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$949 in reported general payments places this provider in the 75th percentile of 1,101 acute care providers in Ohio.

See all acute care providers in Ohio

Medicare billing

Part B allowed, 2024
$5,713
Medicare patients
78
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor124$59,893
XareltoRivaroxaban34$18,853
EliquisApixaban19$10,992
ClopidogrelClopidogrel Bisulfate285$2,302
Atorvastatin Calcium168$1,143
Rosuvastatin Calcium50$658
Amiodarone Hcl56$424
Colchicine35$306
Flecainide Acetate13$259
Pantoprazole Sodium48$198
Metoprolol Succinate42$148
Cephalexin23$74
Metoprolol Tartrate25$54
Furosemide23$23
Spironolactone15$22

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$95$59,893124 claims
PfizerEliquis$74$10,99219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,101 acute care providers in Ohio.

Other acute care in Parma

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →